

| Revenue | $10 - $100 million See Exact Annual Revenue |
|---|---|
| Employees | 10 - 100Exact Company Size |
| Primary Industry | 621511 Medical Laboratories |
| Additional NAICS Codes | 325412 Pharmaceutical Preparation Manufacturing 621112 Physicians, Mental Health Specialists |
| Address | 15 Cushing Irvine, CA 92618 |
| Oncocyte | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $10 - $100 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Oncocyte P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| ONCOTIME Research use only chemical reagents for clinical medical or veterinary purposes; diagnostic reagents for medicinal research use | 11/15/2023 |
| GRAFTASSURE Research use only transplant test kits using digital polymerase chain reaction technology to measure and test the concentration of donor-derived cell free DNA in a single nucleotide polymorphism gene; test kits for use in measuring DNA levels for transplant research purposes; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in transplantation monitoring and transplantation therapy evaluation | 10/05/2023 |
| GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING Research use only transplant test kits using digital polymerase chain reaction technology to measure and test the concentration of donor-derived cell free DNA in a single nucleotide polymorphism gene; test kits for use in measuring DNA levels for transplant research purposes; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in transplantation monitoring and transplantation therapy evaluation | 10/05/2023 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| PHYSICIANS IMMUNODIAGNOSTIC LABORATORY | Burbank, CA | 100 |
| ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY | Linden, NJ | 100 |
| CENTOGENE US | Cambridge, MA | 88 |
| LATARA ENTERPRISE | Pomona, CA | 61 |
| TELIGENT PHARMA | Vineland, NJ | 46 |
| COVID CLINIC | Huntington Beach, CA | 37 |
| VIKOR SCIENTIFIC | Charleston, SC | 33 |
| BIOTHERANOSTICS | San Diego, CA | 31 |
| SHERMAN-ABRAMS LABORATORY | Brooklyn, NY | 31 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| JAMES R. GLIDEWELL DENTAL CERAMICS | Newport Beach, CA | 100 |
| INARI MEDICAL | Irvine, CA | 32 |
| ALLIANCE HEALTHCARE SERVICES | Irvine, CA | 25 |
| CAP DIAGNOSTICS | Irvine, CA | 7 |
| COVID CLINIC | Huntington Beach, CA | 3 |
| MDXHEALTH | Irvine, CA | 3 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| MERCHSOURCE | Irvine, CA | 100 |
| COHESION PRODUCTS | Irvine, CA | 0 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |